ľ�ϸ���Ӱ��

Beyond the need for adjustments in biochemistry and immunology textbooks, the new finding also carries implications for therapeutic applications.

Many cancer drugs recently approved by the European Medicines Agency (EMA) lack clear proof of added benefit. This is particularly the case for drugs that are granted via special processes, intended to accelerate the approval of promising treatments.

Associate professor Robert de Vries has been awarded a 150.000 Euro Proof of Concept Grant by the European Research Council (ERC).

Certain non-digestible sugar structures used in nasal sprays can reduce bacterial infections in the lungs.

Immunologist Gestur Vidarsson studies how a sugar present in antibodies helps reduce immune responses. Taking the sugar out can strengthen the immune response.

Upon his retirement from Utrecht ľ�ϸ���Ӱ��, clinical pharmacologist Prof. Ton de Boer was appointed Officer in the Order of Oranje Nassau.

The Dutch platform DARE-NL has been awarded a €5.3 million grant from KWF Dutch Cancer Society, aiming to make cell and gene available to more patients.

Five students of Pharmaceutical sciences receive national awards.

Prof. Roos Masereeuw has been appointed vice-dean of research at the Faculty of Science. Her term will start 1 February 2023.

By starting a company, PhD candidate Lucas Czentner takes an important step towards realizing clinical trials of a new cancer treatment.

Gardarsdottir and her team use real world data to enable healthcare providers and regulatory bodies to make well-informed decisions about treatment.

Awards

Utrecht researchers coordinate four studies commissioned by the European Medicines Authority into drug use during pregnancy.

Utrecht is part of an Innovative Medicines Initiative that bring clinical trials to the participant's home.

Utrecht researchers publish new technology for measuring protein activity in cells, which enables detection of diseases such as cancer at an early stage.

Pharmacy student Hanne Borgers has won the NK-Consultation this year. This makes her the best pharmacist student in helping patients.

Utrecht scientists collected thousands of fungal products, that offer ample opportunity to search for new drugs.

An estimated one fifth of all secondary school pupils in the Netherlands who use ADHD medicines use medication like methylphenidate for non-medical reasons

Bedside development and production could be a break through for personalised medication, asserts prof. Huub Schellekens in Nature Biotechnology

Ton de Boer, Professor of Pharmacotherapy at Utrecht ľ�ϸ���Ӱ��, will be appointed as the new Chairman of the Medicines Evaluation Board of the Netherlands.